Tumor profiling in pancreatic carcinoma, a multidisciplinary initiative

Tumor profiling in pancreatic carcinoma, a multidisciplinary initiative - Pancreas bio bank project

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35953

Enrollment

200

Registered

2011-11-03

Start date

2011-09-22

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer pancreatic carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Suspicion of potentially resectable and irresectable pancreatic malignancy on preoperative imaging

Exclusion criteria

Exclusion criteria: Not able to give informed consent

Design outcomes

Primary

Measure	Time frame
The expression of stem cell markers in cell cultures and xenograft models, serum protein markers, and DNA/RNA profiles, will be correlated to clinicopathological characteristics like survival and TNM classification.	—

Secondary

Measure	Time frame
Amount of viable tumor cells in biopsies taken at the OR/Pathology (quality comparison). Optimal procedures for processing of the tissues (we follow standard operating procedures in the laboratories).	—

Countries

Netherlands

Outcome results